Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hicks

Showing results (791-800 of 1,000) with videos related to

Pageof 100
Sort By:
American Journal of Clinical Oncology|July 8, 2009
Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neckSusan A McCloskey, Wainwright Jaggernauth, Nestor R Rigual, et al.
Asian Journal of Urology|February 19, 2019
If this is true, what does it imply? How end-user antibody validation facilitates insights into biology and diseaseKaren S Sfanos, Srinivasan Yegnasubramanian, William G Nelson, et al.
NPJ Digital Medicine|March 19, 2023
A scoping review of portable sensing for out-of-lab anterior cruciate ligament injury prevention and rehabilitationTian Tan, Anthony A Gatti, Bingfei Fan, et al.
NPJ Digital Medicine|October 16, 2024
A randomized clinical trial testing digital mindset intervention for knee osteoarthritis pain and activity improvementMelissa A Boswell, Kris M Evans, Disha Ghandwani, et al.
Pathology|April 5, 2025
Overexpression of fibroblast activation protein (FAP) in the stroma of proliferative inflammatory atrophy (PIA) and primary adenocarcinoma of the prostateFernanda Caramella-Pereira, Qizhi Zheng, Jessica L Hicks, et al.
Medrxiv : the Preprint Server for Health Sciences|April 18, 2024
Overexpression of Fibroblast Activation Protein (FAP) in stroma of proliferative inflammatory atrophy (PIA) and primary adenocarcinoma of the prostateFernanda Caramella-Pereira, Qizhi Zheng, Jessica L Hicks, et al.
Transfusion|March 27, 2007
Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cellsMichelle L Hicks, Sagar Lonial, Amelia Langston, et al.
Ecancermedicalscience|February 28, 2024
Gynaecologic oncology surgical cancellations in ZambiaSamson Chisele, Mulindi Mwanahamuntu, Paul Kamfwa, et al.
Cancer|June 8, 2012
An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomyEmmanuel S Antonarakis, Daniel Keizman, Zhe Zhang, et al.
Plos One|September 1, 2017
Mouse models of human ocular disease for translational researchMark P Krebs, Gayle B Collin, Wanda L Hicks, et al.
Pageof 100

Showing results (791-800 of 1,000) with videos related to

Sort By:
Pageof 100
American Journal of Clinical Oncology|July 8, 2009
Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neckSusan A McCloskey, Wainwright Jaggernauth, Nestor R Rigual, et al.
Asian Journal of Urology|February 19, 2019
If this is true, what does it imply? How end-user antibody validation facilitates insights into biology and diseaseKaren S Sfanos, Srinivasan Yegnasubramanian, William G Nelson, et al.
NPJ Digital Medicine|March 19, 2023
A scoping review of portable sensing for out-of-lab anterior cruciate ligament injury prevention and rehabilitationTian Tan, Anthony A Gatti, Bingfei Fan, et al.
NPJ Digital Medicine|October 16, 2024
A randomized clinical trial testing digital mindset intervention for knee osteoarthritis pain and activity improvementMelissa A Boswell, Kris M Evans, Disha Ghandwani, et al.
Pathology|April 5, 2025
Overexpression of fibroblast activation protein (FAP) in the stroma of proliferative inflammatory atrophy (PIA) and primary adenocarcinoma of the prostateFernanda Caramella-Pereira, Qizhi Zheng, Jessica L Hicks, et al.
Medrxiv : the Preprint Server for Health Sciences|April 18, 2024
Overexpression of Fibroblast Activation Protein (FAP) in stroma of proliferative inflammatory atrophy (PIA) and primary adenocarcinoma of the prostateFernanda Caramella-Pereira, Qizhi Zheng, Jessica L Hicks, et al.
Transfusion|March 27, 2007
Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cellsMichelle L Hicks, Sagar Lonial, Amelia Langston, et al.
Ecancermedicalscience|February 28, 2024
Gynaecologic oncology surgical cancellations in ZambiaSamson Chisele, Mulindi Mwanahamuntu, Paul Kamfwa, et al.
Cancer|June 8, 2012
An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomyEmmanuel S Antonarakis, Daniel Keizman, Zhe Zhang, et al.
Plos One|September 1, 2017
Mouse models of human ocular disease for translational researchMark P Krebs, Gayle B Collin, Wanda L Hicks, et al.
Pageof 100